Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/167536
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Sánchez-Elexpuru, Gentzane | es_ES |
dc.contributor.author | Serratosa, José M. | es_ES |
dc.contributor.author | Sanz, Pascual | es_ES |
dc.contributor.author | Sánchez, Marina P. | es_ES |
dc.date.accessioned | 2018-07-11T06:59:37Z | - |
dc.date.available | 2018-07-11T06:59:37Z | - |
dc.date.issued | 2017-03-22 | - |
dc.identifier.citation | NeuroReport 28(5):268-271 (2017) | es_ES |
dc.identifier.issn | 0959-4965 | - |
dc.identifier.uri | http://hdl.handle.net/10261/167536 | - |
dc.description | 4 Páginas, 1 Figura | es_ES |
dc.description.abstract | Lafora disease (LD) is a rare adolescent-onset progressive myoclonic epilepsy caused by loss-of-function mutations either in the EPM2A gene encoding laforin or in the EPM2B gene encoding malin. Mouse models with deletion in the Epm2a or the Epm2b gene show intracellular aggregates of polyglucosans (Lafora bodies) and neurological complications that resemble those observed in patients with LD. In the absence of laforin or malin expression, mice also show different degrees of hyperexcitability, as reflected by an enhanced response to the convulsant drug pentylenetetrazol (PTZ). Malin knockout mice treated with 4-phenylbutyric acid (4-PBA) and metformin showed decreased amounts of Lafora bodies and polyubiquitin protein aggregates in the brain, diminished neurodegeneration, and amelioration of some neurological conditions. In this study, we analyzed the action of 4-PBA and metformin treatments on response to PTZ in a malin knockout model of LD. Both treatments decreased seizure susceptibility, bringing about a reduction in both seizure number and length, and eliminated the mortality induced by PTZ. These results show a neuroprotective role of 4-PBA and metformin and extend the beneficial effects reported in the malin knockout model of LD Video abstract: http://links.lww.com/WNR/A411. | es_ES |
dc.description.sponsorship | This work was supported by grants from the Fondo de Investigación Sanitaria / Carlos III Institute of Health (PI13/00865) from the Spanish Ministry of Health (FEDER), the Spanish Ministry of Economy (SAF2014-59594-R to JMS) and by the Centro de Investigacion Biomedica en Red de Enfermedades Raras, CIBERER. GSE is supported by a fellowship from the Fundacion Conchita Rabago | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Lippincott Williams & Wilkins | es_ES |
dc.relation | MINECO/SAF2014/59594/R | es_ES |
dc.relation.isversionof | Postprint | es_ES |
dc.rights | openAccess | es_ES |
dc.subject | Lafora disease | es_ES |
dc.subject | Epilepsy | es_ES |
dc.subject | Oxidative stress | es_ES |
dc.subject | Autophagy | es_ES |
dc.subject | PTZ | es_ES |
dc.subject | Malin knockout mouse | es_ES |
dc.title | 4-Phenylbutyric acid and metformin decrease sensitivity to pentylenetetrazol-induced seizures in a malin knockout model of Lafora disease. | es_ES |
dc.type | artículo | es_ES |
dc.identifier.doi | 10.1097/WNR.0000000000000751 | - |
dc.description.peerreviewed | Peer reviewed | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1097/WNR.0000000000000751 | es_ES |
dc.identifier.e-issn | 1473-558X | - |
dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
dc.contributor.funder | Ministerio de Economía y Competitividad (España) | es_ES |
dc.contributor.funder | Centro de Investigación Biomédica en Red Enfermedades Raras (España) | es_ES |
dc.relation.csic | Sí | es_ES |
oprm.item.hasRevision | no ko 0 false | * |
dc.identifier.funder | http://dx.doi.org/10.13039/501100004587 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100003329 | es_ES |
dc.contributor.orcid | Sanz, Pascual [0000-0002-2399-4103] | es_ES |
dc.identifier.pmid | 28181916 | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.fulltext | With Fulltext | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | artículo | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | open | - |
Aparece en las colecciones: | (IBV) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
2017 Neuroreport 28-268.pdf | 187,39 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
18
checked on 22-abr-2024
SCOPUSTM
Citations
30
checked on 19-abr-2024
WEB OF SCIENCETM
Citations
29
checked on 24-feb-2024
Page view(s)
346
checked on 24-abr-2024
Download(s)
203
checked on 24-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.